Product Spotlight: Aniara Diagnostica would like to announce the availability of T cell ELISPOT assays

Share Article

Aniara Diagnostica is pleased to announce the availability of T cell ELISPOT assays for COVID-19 vaccine research.

News Image
The entire Aniara line is available for purchase at http://www.aniara.com.

Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.

For Research Use Only. Not for Use in Diagnostic Procedures.

T cell ELISPOT assays are extremely effective for COVID-19 vaccine research. Because Human and monkey research is critical in the COVID-19 field, IFN-gamma T cell ELISPOT assays are an attractive tool to determine the number of COVID-specific IFN-gamma producing T cells in the circulation of human and non-human primates.

A cytokine assay that has also been reported to be important for COVID-19 research is the IL-6 ELISA (cytokine ELISA kit).

ACT230-PR5 Human IFN-γ ELISPOT kit click here for more information
ACT121-PR5 Monkey IFN-y ELISPOT kit click here for more information
ACT640-20 Human IFN- IFN-y ELISPOT antibody pair click here for more information
ACT605-20 Monkey IFN-γ ELISPOT Antibody Pair click here for more information
ACT205A Human IL-6 ELISA click here for more information

The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maria Waldron
Visit website